Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC Study

• मुख्य लेखकों: Mario Ouwens, PhD (लेखक), Annie Darilay, PhD (लेखक), Yiduo Zhang, PhD (लेखक), Pralay Mukhopadhyay, PhD (लेखक), Helen Mann, MSc (लेखक), James Ryan, MSc (लेखक), Phillip A. Dennis, MD (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2021-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

ABSTRACT: Background: Historically, the standard of care for patients with unresectable, Stage III non-small cell lung cancer had been concurrent chemoradiotherapy. However, outcomes had been poor, with approximately 15% to 32% of patients alive at 5 years. In the placebo-controlled Phase III A PACI...